Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K. Moore, Livia A. Veress, Michael B. Yaffe, Hunter B. Moore, Christopher D. Barrett
Topics & Concepts
ARDSMedicineIntensive care medicineMechanical ventilationCoagulopathyDiffuse alveolar damageRespiratory failurePulmonary complianceRespiratory distressLungInternal medicineSurgeryAcute respiratory distressCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms